ALB and stage 5 chronic kidney disease: Furthermore, patients with HbA1c > 9%, a higher visit-to-visit CV% of pre-meal blood glucose/HbA1c, worsening renal function (adjusted HR of patients with chronic kidney disease stage 5 and estimated glomerular filtration < 15: 1.68; 95% CI: 1.54–1.83), low-density lipoprotein > 130 mg/dL (adjusted HR: 1.06; 95% CI: 1.04–1.08), higher triglyceride levels, and severe proteinuria (measured by urine albumin-to-creatinine ratio of random urine specimen, UACR) also had a higher risk of cardiovascular disease (Table 3).